Locations:
Search IconSearch

Dr. Jason Jerry Among Recipients of National Honor for Anti-Opioid Efforts

U.S. AG’s Award recognizes model now being replicated nationwide

16-neu-2604-doj-650×450
jason-jerry

Jason Jerry, MD

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Members of the U.S. Attorney’s Northeast Ohio Heroin and Opioid Task Force — including Cleveland Clinic addiction psychiatrist Jason Jerry, MD — have been granted the U.S. Attorney General’s Award, the most prestigious honor given by the federal Department of Justice, for their work combating opioid addiction in greater Cleveland.

They accepted the award in Washington, D.C., on Nov. 10 from Attorney General Loretta Lynch, fifth from the left in the photo above (Dr. Jerry is next to her, sixth from the left).

Recognizing the ‘Cleveland Model’

Dr. Jerry, a specialist in addiction and recovery, has been involved with the Northeast Ohio Heroin and Opioid Task Force since its formation in 2013 to address the region’s significant opioid addiction epidemic. His roles have included service as chairman of its treatment subcommittee.

The task force focuses on solutions to the epidemic from four perspectives — law enforcement, education and prevention, healthcare policy, and treatment. Task force members include law enforcement officials, physicians and other treatment professionals, people in recovery, judges, public health professionals, educators and others.

“It’s great to see the task force be recognized for all the hard work that’s been devoted to this effort,” says Dr. Jerry. “We still have a long way to go, but our work thus far is important and is being replicated by other U.S. Attorney’s offices around the country. We understand the model of our task force is being called the ‘Cleveland Model’.”

Combating addiction on multiple fronts

The award — known in full as the U.S. Attorney General’s Award for Outstanding Community Partnerships for Public Safety — recognizes achievement in the development and support of community partnerships designed to address public safety within a community.

Advertisement

Specific accomplishments of the Northeast Ohio Heroin and Opioid Task Force that contributed to the recognition include:

  • Efforts to make naloxone more readily available throughout the region
  • Presentations to tens of thousands of parents, students and other community members at hundreds of town hall meetings and schools
  • Increased training for physicians and other health providers about the dangers of opioids
  • Creation of a heroin-involved death investigation team that treats sites of overdoses as crime scenes to support enhanced criminal charges for dealers when appropriate
  • Work to increase the availability of drug treatment for addiction

“It is easy to become discouraged about the wave of death and pain that opioids and heroin bring to our community,” says U.S. Attorney Carole Rendon, who chairs the task force. “But I know the incredible efforts of all the members of this team make a difference on a daily basis. This approach has become a national model.”

Advertisement

Related Articles

16-NEU-2800-Kubu-101058161-650×450

What Do Patients Want from DBS for Parkinson’s Disease?

New study advances understanding of patient-defined goals

photo of a man sleeping at a desk, with a podcast icon overlay
March 15, 2024/Neurosciences/Podcast

Diagnosis and Management of Idiopathic Hypersomnia (Podcast)

Testing options and therapies are expanding for this poorly understood sleep disorder

illustration of an alzheimer brain and a packet of sildenafil pills
March 11, 2024/Neurosciences/Research

Sildenafil as an Alzheimer’s Candidate Drug: Further Support From Insurance Database and Mechanistic Studies

Real-world claims data and tissue culture studies set the stage for randomized clinical testing

brain scan showing perimesencephalic subarachnoid hemorrhage

Study Supports Less-Strict Monitoring for Nonaneurysmal Perimesencephalic SAH Without Hydrocephalus

Digital subtraction angiography remains central to assessment of ‘benign’ PMSAH

illustrated brain with the letters "AI" on a computer circuit board

As AI Tools Emerge, Be Proactive and Engaged to Shape Their Development

Cleveland Clinic neuromuscular specialist shares insights on AI in his field and beyond

histology image of a gray matter lesion in a multiple sclerosis brain

Study Suggests Protective Role for Microglia at Borders of Gray Matter Lesions in Progressive MS

Findings challenge dogma that microglia are exclusively destructive regardless of location in brain

series of digital-looking brain icons with a podcast button overlay on top
March 1, 2024/Neurosciences/Podcast

Harnessing the Power of AI in Medicine (Podcast)

Neurology is especially well positioned for opportunities to enhance clinical care and medical training

illustration of a neuron affected by multiple sclerosis

Clinical Trials in Progressive MS: An Assessment of Advances and Remaining Challenges

New review distills insights from studies over the past decade

Ad